The Winniedel Oncology Blog
At Winniedel Oncology, we specialize in expediting study start-up (SSU) for early-phase (FIH-2b) oncology clinical trials. Discover how our expertise can streamline your clinical development journey and make a meaningful impact in the fight against cancer.
From Politics to Patients: The Real Cost of Slashed Biotech Budgets
… And how a niche CRO might just save the day.
WINNIEDEL ONCOLOGY and Exact Clinical Research Announce Strategic Partnership to Accelerate and Optimize Early-Phase Cancer Trials
WINNIEDEL ONCOLOGY and Exact Clinical Research Announce Strategic Partnership to Accelerate and Optimize Early-Phase Cancer Trials
WINNIEDEL ONCOLOGY and CLINEXEL Enter Strategic Partnership to Advance Global Oncology Research
WINNIEDEL ONCOLOGY and CLINEXEL Enter Strategic Partnership to Advance Global Oncology Research
The Importance of Site Selection in Oncology Trials: Finding Your Perfect Glass Slipper
From experience, matching the right sites for a clinical trial can sometimes feel like searching for Cinderella the day after the ball.
This is true for clinical trials in general, but becomes even more real when faced with the complex protocols and specialized needs of an early-phase oncology trial. Identifying the right clinical sites is paramount to ensure FPI, efficient patient enrollment, adherence to protocols, data efficacy and the overall integrity of the study. Site selection just isn’t something you can do half-baked. But how do you do it “right”?
Rescue Studies in Oncology: Turning Around Challenged Clinical Trials
Rescue Studies in Oncology: Turning Around Challenged Clinical Trials
Overcoming Roadblocks in Early-Phase Oncology Trials
Market Insights, Pulled Straight from LinkedIn
Market Insights, Pulled Straight from LinkedIn
Navigating the Future of Oncology Clinical Research Organizations (CROs): Trends to Watch in 2025
Navigating the Future of Oncology Clinical Research Organizations (CROs): Trends to Watch in 2025